Overall rank by patents
#31,163
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 20 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: Y02P (CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS).
The verdict
Chulalongkorn holds 8 US patents across 20 technology areas, rank #31,163 of 50,000 tracked assignees.
Chulalongkorn University has been granted 8 US utility patents between 2015 and 2025, placing Chulalongkorn University at rank #31,163 across all assignees tracked by PlainPatent. This portfolio spans 20 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.9 claims per patent with primary concentration in Y02P (CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS). As a Foreign Corporation, Chulalongkorn University is one of the more focused assignees in the PatentsView dataset. By volume, Chulalongkorn sits between Chiome Bioscience Inc. (8 patents, rank #31,159) and CIMC Containers Holding Company Ltd. (8 patents, rank #31,167) - the closest US assignees by grant volume. The composite Innovation Score of 43.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 4 in the 2015–2019 window, a +0% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Chulalongkorn University's 11.9 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 20 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Chulalongkorn University against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CHIOME BIOSCIENCE INC.
8 patents
CHO PHARMA, INC.
8 patents
CHR.MAYR GMBH + CO. KG
8 patents
CHRISTIANA CARE HEALTH SYSTEM, INC.
8 patents
CHUN KUANG OPTICS CORP.
8 patents
CHUNG-HSIN ELECTRIC &MACHINERY MFG. CORP.
8 patents
CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO. LTD.
8 patents
CIMC CONTAINERS HOLDING COMPANY LTD.
8 patents
CHULALONGKORN UNIVERSITY
8 patents
What this shows Chulalongkorn holds 8 patents at rank #31,163, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #31,163 in granted patent volume.
Other assignees with the most granted patents in Chulalongkorn's primary technology class.
Chulalongkorn's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
44 Top 27% higher than 73% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 25.0% |
| 2017 | 2 | 25.0% |
| 2022 | 1 | 12.5% |
| 2024 | 1 | 12.5% |
| 2025 | 2 | 25.0% |
Top 15 of 20 technology areas
Overall rank by patents
#31,163
Across all tracked assignees
43.9 out of 100
How to use this portfolio
Chulalongkorn's 8 grants land it in the top 27% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.